✦ LIBER ✦

Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls

✍ Scribed by Bjorn WH van Heumen,Hennie MJ Roelofs…

Book ID: 126377679
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 211 KB
Volume: 8
Category: Article
ISSN: 1750-1172
DOI: 10.1186/1750-1172-8-181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid counteracts celecox

Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial

✍ van Heumen, Bjorn WH; Roelofs, Hennie MJ; Vink-Börger, M; Dekker, Evelien; Mathu 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 353 KB

Randomized controlled trial of the effec

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

✍ K. P. Nugent; K. C. R. Farmer; A. D. Spigelman; C. B. Williams; Mr R. K. S. Phil 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

A randomized trial comparing ursodeoxych

A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective Cox-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis

✍ Maclean, Anthony R.; McLeod, Robin S.; Berk, Terri; Gallinger, Steven 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB